|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Proteasome inhibitor treatment in alcoholic liver disease显示文摘Oxidative stress, generated by chronic ethanol consumption, is a major cause of hepatotoxicity and liver injury. Increased production of oxygen-derived free radicals due to ethanol metabolism by CYP2E1 is principally located in the cytoplasm and in the mitochondria, which does not only injure liver cells, but also other vital organs, such as the heart and the brain. Therefore, there is a need for better treatment to enhance the antioxidant response elements. To date, there is no established treatment to attenuate high levels of oxidative stress in the liver of alcoholic patients. To block this oxidative stress, proteasome inhibitor treatment has been found to significantly enhance the antioxidant response elements of hepatocytes exposed to ethanol. Recent studies have shown in an experimental model of alcoholic liver disease that proteasome inhibitor treatment at low dose has cytoprotective effects against ethanol-induced oxidative stress and liver steatosis. The beneficial effects of proteasome inhibitor treatment against oxidative stress occurred because antioxidant response elements (glutathione peroxidase 2, superoxide dismutase 2, glutathione synthetase, glutathione reductase, and GCLC) were upregulated when rats fed alcohol were treated with a low dose of PS-341 (Bortezomib, Velcade ). This is animportant finding because proteasome inhibitor treatment up-regulated reactive oxygen species removal and glutathione recycling enzymes, while ethanol feeding alone down-regulated these antioxidant elements. For the first time, it was shown that proteasome inhibition by a highly specific and reversible inhibitor is different from the chronic ethanol feeding-induced proteasome inhibition. As previously shown by our group, chronic ethanol feeding causes a complex dysfunction in the ubiquitin proteasome pathway, which affects the proteasome system, as well as the ubiquitination system. The beneficial effects of proteasome inhibitor treatment in alcoholic liver disease are related to proteasome inhibitor reversibility and the rebound of proteasome activity 72 h post PS-341 administration. | Fawzia Bardag-Gorce | 2011 | World Journal of Gastroenterology2011，17，20： | 4 |
| 2 | Nuclear effects of ethanol-induced proteasome inhibition in liver cells显示文摘Alcohol ingestion causes alteration in several cellular mechanisms, and leads to inflammation, apoptosis, immunological response defects, and fibrosis. These phenomena are associated with significant changes in the epigenetic mechanisms, and subsequently, to liver cell memory. The ubiquitin-proteasome pathway is one of the vital pathways in the cell that becomes dysfunctionial as a result of chronic ethanol consumption. Inhibition of the proteasome activity in the nucleus causes changes in the turnover of transcriptional factors, histone modifying enzymes, and therefore, affects epigenetic mechanisms. Alcohol consumption has been associated with an increase in histone acetylation and a decrease in histone methylation, which leads to gene expression changes. DNA and histone modifications that result from ethanol-induced proteasome inhibition are key players in regulating gene expression, especially genes involved in the cell cycle, immunological responses, and metabolism of ethanol. The present review highlights the consequences of ethanol-induced proteasome inhibition in the nucleus of liver cells that are chronically exposed to ethanol. | Fawzia Bardag-Gorce | 2009 | World Journal of Gastroenterology2009，15，10： | 4 |
| 3 | 慢性酒精中毒性疾病与泛素-蛋白酶体途径异常调节的研究显示文摘泛素-蛋白酶体途径是细胞内蛋白质降解的主要途径,在多种细胞生命过程中发挥重要作用。目前研究证实慢性酒精中毒可导致泛素-蛋白酶体途径异常调节,主要涉及蛋白酶体活性、泛素分子合成以及相关蛋白分子表达改变等,并且与一些慢性酒精中毒性疾病的发生有关,包括酒精中毒性肝病、酒精中毒性脑病和酒精中毒性肌病。这些发现为进一步揭示酒精诱导损伤的分子机制以及研发治疗慢性酒精中毒性疾病的新型药物提供了重要的研究方向。 | 杨海玉 刘勇 | 2014 | 南昌大学学报(医学版)2014，54，1： | 3 |
| 4 | 酒精与肝脏脂质代谢显示文摘酒精滥用是一个重大的公共健康问题。酒精通过刺激脂肪酸合成,抑制脂肪酸的氧化导致肝脏脂质积累,进而诱发肝细胞病变,导致脂肪肝的病发。从转录调控脂质代谢的改变,异常甲硫氨酸代谢对内质网应激反应的作用等方面概述酒精与脂质代谢的相互调控机制,并阐述了这些调控机制之间的内在联系以及酒精如何影响肝脏脂质代谢,从而导致脂肪肝形成的最新相关研究进展。 | 朱雅丽 季晨阳 乐佳清 吴俊俊 王楠 富浩轩 吴涛 | 2014 | 生命科学2014，26，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员